hydroquinone has been researched along with Lentigines in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "01% (Solagé) was compared with its active components, its vehicle, and hydroquinone (HQ) 3% in the treatment of solar lentigines." | 9.11 | Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. ( Jarratt, M, 2004) |
| "To assess sensitive and objective methods predicting the effects of a 2% hydroquinone-cyclodextrin formulation on solar lentigines." | 9.10 | Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation. ( Petit, L; Piérard, GE, 2003) |
| "Although bleaching treatment using all-trans retinoic acid (RA) and hydroquinone (HQ) improves epidermal melanosis, the application of two medications and the irritant dermatitis induced by RA inconvenience patients." | 7.79 | Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis. ( Harii, K; Iida, S; Kurita, M; Ohura, N; Sato, S; Takushima, A, 2013) |
| "01% (Solagé) was compared with its active components, its vehicle, and hydroquinone (HQ) 3% in the treatment of solar lentigines." | 5.11 | Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. ( Jarratt, M, 2004) |
| "To assess sensitive and objective methods predicting the effects of a 2% hydroquinone-cyclodextrin formulation on solar lentigines." | 5.10 | Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation. ( Petit, L; Piérard, GE, 2003) |
| "Although bleaching treatment using all-trans retinoic acid (RA) and hydroquinone (HQ) improves epidermal melanosis, the application of two medications and the irritant dermatitis induced by RA inconvenience patients." | 3.79 | Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis. ( Harii, K; Iida, S; Kurita, M; Ohura, N; Sato, S; Takushima, A, 2013) |
| "Hydroquinone is a well known reagent used in the treatment of pigmentation disorders." | 1.30 | Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis. ( Barel, A; Clarys, P, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreher, F | 1 |
| Draelos, ZD | 1 |
| Gold, MH | 1 |
| Goldman, MP | 1 |
| Fabi, SG | 1 |
| Puissegur Lupo, ML | 1 |
| Iida, S | 1 |
| Takushima, A | 1 |
| Ohura, N | 1 |
| Sato, S | 1 |
| Kurita, M | 1 |
| Harii, K | 1 |
| Hexsel, D | 1 |
| Hexsel, C | 1 |
| Porto, MD | 1 |
| Siega, C | 1 |
| Imhof, L | 1 |
| Dummer, R | 1 |
| Dreier, J | 1 |
| Kolm, I | 1 |
| Barysch, MJ | 1 |
| Petit, L | 1 |
| Piérard, GE | 1 |
| Jarratt, M | 1 |
| Cayce, KA | 1 |
| McMichael, AJ | 1 |
| Feldman, SR | 1 |
| Boissy, RE | 1 |
| Visscher, M | 1 |
| DeLong, MA | 1 |
| Clarys, P | 1 |
| Barel, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Solar Lentigines Treatment With the Triple Combination Cream (Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01%). Randomized, Double Blind, Controlled Trial.[NCT00975312] | Phase 2 | 22 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroquinone and Lentigines
| Article | Year |
|---|---|
Hyperpigmentation: an overview of the common afflictions.
Topics: Chemexfoliation; Cryotherapy; Dermatologic Agents; Dicarboxylic Acids; Humans; Hydroquinones; Hyperp | 2004 |
4 trials available for hydroquinone and Lentigines
| Article | Year |
|---|---|
Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Chemotherapy, Adjuvant; Cryotherapy; | 2015 |
A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines.
Topics: Aged; Dexamethasone; Drug Combinations; Erythema; Female; Hand Dermatoses; Humans; Hydroquinones; La | 2016 |
Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 2003 |
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Double-Blind Method; Drug Thera | 2004 |
4 other studies available for hydroquinone and Lentigines
| Article | Year |
|---|---|
Efficacy of hydroquinone-free skin-lightening cream for photoaging.
Topics: Administration, Cutaneous; Adult; Aged; California; Dermatologic Agents; Drug Combinations; Female; | 2013 |
Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis.
Topics: Adult; Aged; Antioxidants; Drug Therapy, Combination; Female; Humans; Hydroquinones; Keratolytic Age | 2013 |
DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
Topics: Agaricales; Animals; Arbutin; Cell Proliferation; Clinical Trials as Topic; Dose-Response Relationsh | 2005 |
Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Apiaceae; Ascorbic Acid; Benzoyl Peroxide; Citru | 1998 |